The results suggested that ATR-II had chemopreventive effects on E2-induced anchorage-independent growth of MCF 10A cells and NMU-induced mammary tumor progression in rats through the induction of Nrf2 and its downstream detoxifying enzymes expression via JNK/ERK-Nrf2-ARE-dependent pathways. Here, MAPK8 is linked to breast cancer.